Source:http://linkedlifedata.com/resource/pubmed/id/12599534
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2003-2-25
|
pubmed:abstractText |
Antimicrobial susceptibility testings of 24 antimicrobial agents against 605 clinical strains belonging to 10 species were carried out according to the micro-broth dilution method of NCCLS M7-A4. The productivity of beta-lactamase was also determined against them isolated at 8 medical facilities in Nagano prefecture, Japan during the period between December 1999 and February 2000. When applied the nitrocefin method, beta-lactamase productivity was demonstrated to be positive for 89.2% of 74 S. aureus, 4.3% of 94 H. influenzae, and 100% of 69 M. (B.) catarrhalis isolates. On the other hand, when used the acidometry method, penicillinase/cephalosporinase were found to be positive for 21.2%/9.6% of 52 E. coli, 29.0%/3.2% of 31 K. pneumoniae, 53.2%/100% of 47 E. cloacae, 0%/11.1% of 99 S. marcescens, and 25.9%/55.6% of 54 P. aeruginosa isolates, respectively. Among the beta-lactamase-producers including P. aeruginosa isolates, only 2 E. coli isolates were found to be ESBL-producers. Besides, 9.6% (9/94) of H. influenzae isolates were proved to be BLNAR strains.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0368-2781
|
pubmed:author |
pubmed-author:FujikiKyokoK,
pubmed-author:HaketaMakioM,
pubmed-author:IdeKyokoK,
pubmed-author:KakegawaJiroJ,
pubmed-author:KobayashiSatoruS,
pubmed-author:NaitohMiharuM,
pubmed-author:NakamuraYasukoY,
pubmed-author:NotakeShigeyukiS,
pubmed-author:OkabeTadashiT,
pubmed-author:OkimuraYukieY,
pubmed-author:ShimazakiYumikoY,
pubmed-author:ShiozawaJunkoJ,
pubmed-author:TodaKenichiK,
pubmed-author:XiaoM CMC,
pubmed-author:YanagisawaHidejiH
|
pubmed:issnType |
Print
|
pubmed:volume |
55 Suppl A
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
111-8
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:12599534-Bacteria,
pubmed-meshheading:12599534-Drug Resistance, Bacterial,
pubmed-meshheading:12599534-Enterobacter cloacae,
pubmed-meshheading:12599534-Enterococcus faecalis,
pubmed-meshheading:12599534-Enterococcus faecium,
pubmed-meshheading:12599534-Escherichia coli,
pubmed-meshheading:12599534-Haemophilus influenzae,
pubmed-meshheading:12599534-Japan,
pubmed-meshheading:12599534-Klebsiella pneumoniae,
pubmed-meshheading:12599534-Moraxella (Branhamella) catarrhalis,
pubmed-meshheading:12599534-Pseudomonas aeruginosa,
pubmed-meshheading:12599534-Serratia marcescens,
pubmed-meshheading:12599534-Staphylococcus aureus,
pubmed-meshheading:12599534-beta-Lactamases
|
pubmed:year |
2002
|
pubmed:articleTitle |
[Antimicrobial susceptibility and beta-lactamase productivity of recent clinical isolates during the period between December 1999 and February 2000].
|
pubmed:affiliation |
Miroku Medical Laboratory.
|
pubmed:publicationType |
Journal Article,
English Abstract
|